fluticasone propionate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
PAVTIDE ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack AUST R: 208201Active ingredients:
fluticasone propionate
salmeterol xinafoate
Dosage form:
Inhalation, powder for
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
From
22 Aug 2025
to
24 Nov 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is working to expedite the next shipment. Alternative generic products are available.
|
AXOTIDE ACCUHALER fluticasone propionate 250 micrograms powder for inhalation blister pack AUST R: 267491Active ingredients:
fluticasone propionate
Dosage form:
Inhalation, powder for
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800 033109
|
From
16 Sep 2025
to
24 Sep 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
PAVTIDE MDI 125/25 fluticasone propionate 125 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter) AUST R: 208670Active ingredients:
fluticasone propionate
salmeterol xinafoate
Dosage form:
Inhalation, pressurised
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
From
15 Sep 2025
to
23 Sep 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in consumer demand
|
FLIXOTIDE NEBULES fluticasone propionate 2.0mg/2mL inhalation ampoule AUST R: 69002Active ingredients:
fluticasone propionate
Dosage form:
Inhalation, conventional
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
Deletion from market:
19 Nov 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Patients are advised to consult their healthcare professionals to discuss alternative treatment options.
|